Sarcopenia
Zachary Bloomgarden,
Corresponding Author
Zachary Bloomgarden
Department of Medicine, Division of Endocrinology, Diabetes and Bone Disease, Icahn School of Medicine at Mount Sinai, New York, New York, USA
Correspondence
Zachary Bloomgarden, Department of Medicine, Division of Endocrinology, Diabetes and Bone Disease, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Email: [email protected]
Search for more papers by this authorZachary Bloomgarden,
Corresponding Author
Zachary Bloomgarden
Department of Medicine, Division of Endocrinology, Diabetes and Bone Disease, Icahn School of Medicine at Mount Sinai, New York, New York, USA
Correspondence
Zachary Bloomgarden, Department of Medicine, Division of Endocrinology, Diabetes and Bone Disease, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Email: [email protected]
Search for more papers by this author
REFERENCES
- 1Yuan S, Larsson SC. Epidemiology of sarcopenia: prevalence, risk factors, and consequences. Metabolism. 2023; 144:155533.
- 2Gallagher D, Visser M, de Meersman RE, et al. Appendicular skeletal muscle mass: effects of age, gender, and ethnicity. J Appl Physiol. 1985; 83: 229-239.
10.1152/jappl.1997.83.1.229 Google Scholar
- 3Joundi RA, Hu B, Rangarajan S, et al. Activity limitations, use of assistive devices, and mortality and clinical events in 25 high-income, middle-income, and low-income countries: an analysis of the PURE study. Lancet. 2024; 404(10452): 554-569.
- 4Xu M, Gong Y, Yin X. Total and regional fat-to-muscle mass ratio in relation to all-cause and cause-specific mortality in men and women. J Clin Endocrinol Metab. 2024;dgae595. doi:10.1210/clinem/dgae595
- 5Stoessl AJ. Looking beyond the neurological diagnosis: considering frailty. Lancet Neurol. 2024; S1474–4422(24): 355-357.
- 6Dent E, Morley JE, Cruz-Jentoft AJ, et al. Physical frailty: ICFSR international clinical practice guidelines for identification and management. J Nutr Health Aging. 2019; 23(9): 771-787.
- 7Kim DH, Rockwood K. Frailty in older adults. N Engl J Med. 2024; 391(6): 538-548.
- 8Bassil MS, Gougeon R. Muscle protein anabolism in type 2 diabetes. Curr Opin Clin Nutr Metab Care. 2013; 16(1): 83-88.
- 9Chung HY, Cesari M, Anton S, et al. Molecular inflammation: underpinnings of aging and age-related diseases. Ageing Res Rev. 2009; 8(1): 18-30.
- 10Chen Z, Sun J, Shi T, et al. Causal roles of circulating cytokines in sarcopenia-related traits: a Mendelian randomization study. Front Endocrinol. 2024; 15:1370985.
- 11Chen W, You W, Valencak TG, Shan T. Bidirectional roles of skeletal muscle fibro-adipogenic progenitors in homeostasis and disease. Ageing Res Rev. 2022; 80:101682.
- 12Espino-Gonzalez E, Dalbram E, Mounier R, et al. Impaired skeletal muscle regeneration in diabetes: from cellular and molecular mechanisms to novel treatments. Cell Metab. 2024; 36(6): 1204-1236.
- 13Clynes MA, Gregson CL, Bruyère O, Cooper C, Dennison EM. Osteosarcopenia: where osteoporosis and sarcopenia collide. Rheumatology. 2021; 60(2): 529-537.
- 14Gielen E, Dupont J, Dejaeger M, Laurent MR. Sarcopenia, osteoporosis and frailty. Metabolism. 2023; 145:155638.
- 15Kaji H. Crosstalk between muscle and bone. J Bone Miner Metab. 2024; 42(4): 391-398.
- 16Holanda N, Crispim N, Carlos I, Moura T, Nóbrega E, Bandeira F. Musculoskeletal effects of obesity and bariatric surgery⸺a narrative review. Arch Endocrinol Metab. 2022; 66(5): 621-632.
- 17Batsis JA, Villareal DT. Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies. Nat Rev Endocrinol. 2018; 14(9): 513-537.
- 18Cederholm T, Bosaeus I. Malnutrition in adults. N Engl J Med. 2024; 391(2): 155-165.
- 19Nuijten MAH, Eijsvogels TMH, Monpellier VM, Janssen IMC, Hazebroek EJ, Hopman MTE. The magnitude and progress of lean body mass, fat-free mass, and skeletal muscle mass loss following bariatric surgery: a systematic review and meta-analysis. Obes Rev. 2022; 23(1):e13370.
- 20Locatelli JC, Costa JG, Haynes A, et al. Incretin-based weight loss pharmacotherapy: can resistance exercise optimize changes in body composition? Diabetes Care. 2024; 47(10): 1718-1730.
- 21Conte C, Hall KD, Klein S. Is weight loss-induced muscle mass loss clinically relevant? JAMA. 2024; 332: 9-10.
- 22Zheng WH, Zhu YB, Yao Y, Huang HB. Serum creatinine/cystatin C ratio as a muscle mass evaluating tool and prognostic indicator for hospitalized patients: a meta-analysis. Front Med. 2023; 9:1058464.
10.3389/fmed.2022.1058464 Google Scholar
- 23Wang T, Zhu Y, Liu X, et al. Cystatin C and sarcopenia index are associated with cardiovascular and all-cause death among adults in the United States. BMC Public Health. 2024; 24(1): 1972.
- 24Mirzai S, Persits I, Kazibwe R, et al. Relationship between sarcopenia and intensive blood pressure control efficacy and safety: a secondary analysis of SPRINT. Hypertension. 2024; 81(8): e77-e87.
- 25He D, Gao B, Wang J, Yang C, Zhao MH, Zhang L. The difference between cystatin C- and creatinine-based estimated glomerular filtration rate and risk of diabetic microvascular complications among adults with diabetes: a population-based cohort study. Diabetes Care. 2024; 47(5): 873-880.
- 26Yan K, Ma X, Li C, et al. Higher dietary live microbe intake is associated with a lower risk of sarcopenia. Clin Nutr. 2024; 43(7): 1675-1682.
- 27Codella R, Ialacqua M, Terruzzi I, Luzi L. May the force be with you: why resistance training is essential for subjects with type 2 diabetes mellitus without complications. Endocrine. 2018; 62(1): 14-25.
- 28Izquierdo M, Merchant RA, Morley JE, et al. International exercise recommendations in older adults (ICFSR): expert consensus guidelines. J Nutr Health Aging. 2021; 25(7): 824-853.
- 29Lundgren JR, Janus C, Jensen SBK, et al. Healthy weight loss maintenance with exercise, Liraglutide, or both combined. N Engl J Med. 2021; 384(18): 1719-1730.
- 30Jensen SBK, Sørensen V, Sandsdal RM, et al. Bone health after exercise alone, GLP-1 receptor agonist treatment, or combination treatment: a secondary analysis of a randomized clinical trial. JAMA Netw Open. 2024; 7(6):e2416775.
Citing Literature
